NLGN2 and breast cancer: Accordingly, it is rational to surmise that the mitochondrial location of NLGN2 is critical for its prognostic role in breast cancer, and the close association between NLGN2, mitochondria and immune signatures in breast cancer indicates that NLGN2 may play an immunoregulatory role by reversing mitochondrial dysfunction.